ACKR2 and inflammatory bowel disease: A family member efficiently depleting most of the inflammatory CC chemokines, ACKR2 (D6/CCBP2), has been shown to be overexpressed in colon samples from IBD patients and in patients with colitis-associated cancer [17] but downregulated in sporadic CRC [18].